ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $10,254,000 | +36.8% | 110,327 | -12.4% | 0.01% | +16.7% |
Q3 2021 | $7,497,000 | -20.6% | 125,900 | -9.0% | 0.01% | -14.3% |
Q2 2021 | $9,437,000 | -4.2% | 138,375 | -2.5% | 0.01% | 0.0% |
Q1 2021 | $9,849,000 | -12.2% | 141,934 | -2.8% | 0.01% | -22.2% |
Q4 2020 | $11,214,000 | +13.1% | 145,962 | +10.1% | 0.01% | 0.0% |
Q3 2020 | $9,916,000 | +26.0% | 132,583 | +6.0% | 0.01% | +12.5% |
Q2 2020 | $7,872,000 | +63.4% | 125,048 | +9.0% | 0.01% | +33.3% |
Q1 2020 | $4,817,000 | -31.8% | 114,695 | -26.2% | 0.01% | 0.0% |
Q4 2019 | $7,059,000 | +40.4% | 155,425 | +41.5% | 0.01% | +20.0% |
Q3 2019 | $5,029,000 | +34.3% | 109,868 | +72.0% | 0.01% | +25.0% |
Q2 2019 | $3,745,000 | +35.0% | 63,870 | +3.2% | 0.00% | +33.3% |
Q1 2019 | $2,775,000 | +13.6% | 61,893 | -1.3% | 0.00% | 0.0% |
Q4 2018 | $2,442,000 | -22.0% | 62,693 | -7.8% | 0.00% | -25.0% |
Q3 2018 | $3,129,000 | +0.6% | 67,993 | -4.7% | 0.00% | 0.0% |
Q2 2018 | $3,111,000 | +35.9% | 71,346 | +23.1% | 0.00% | +33.3% |
Q1 2018 | $2,290,000 | +31.2% | 57,972 | +12.8% | 0.00% | +50.0% |
Q4 2017 | $1,746,000 | +37.8% | 51,400 | +3.4% | 0.00% | 0.0% |
Q3 2017 | $1,267,000 | +51.2% | 49,700 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $838,000 | – | 49,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |